23andme Holding Co.

Ticker: MEHCQ

Login to get an email when 23andme Holding Co. files a report

Insider Title
2.0, Llc Abeec 10% or greater ownership
Andre J Fernandez Director
Anne Wojcicki Chief Executive Officer, Director, 10% or greater ownership
Capital Global Growth Fund Ii, L.p. Sequoia 10% or greater ownership
Capital Global Growth Ii Principals Fund, L.p. Sequoia 10% or greater ownership
Capital Growth Fund Iii Sequoia 10% or greater ownership
Capital U.s. Growth Fund Vii, L.p. Sequoia 10% or greater ownership
Capital U.s. Growth Fund Viii, L.p. Sequoia 10% or greater ownership
Capital U.s. Growth Vii Principals Fund, L.p. Sequoia 10% or greater ownership
Douglas M Leone 10% or greater ownership
Evan Lovell Director
Frederick Mark Kohler Vice President, People
Global Growth Ii Management, L.p. Sc 10% or greater ownership
Grove Ii, Llc Sequoia 10% or greater ownership
Grove Manager, Llc Sequoia 10% or greater ownership
Iii Management Llc Scgf 10% or greater ownership
Jim Frankola Director
Joseph Anthony Selsavage Chief Financial Actng Ofcr
Kathy L Hibbs Chief Administrative Officer
Kenneth J. Hillan Chief Therapeutics Officer
Mark Edwin Jensen Director
Neal Mohan Director
Patrick S Chung Director
Paul D Johnson Director
Peter J. Taylor Director
Plc Gsk 10% or greater ownership
Rice Valerie Md Montgomery Director
Richard H Scheller Director
Roelof Botha Director
Sandra R Md Hernandez Director
Steven J Schoch Chief Financial Officer
Steven Lemon Vice President, Engineering
Tracy Keim VP, Consumer Marketing Brand
U.s. Growth Vii Management, L.p. Sc 10% or greater ownership
U.s. Growth Viii Management, L.p. Sc 10% or greater ownership
Us (ttgp), Ltd. Sc 10% or greater ownership
William G Richards Head of Therapeutics Discovery